Kiniksa Pharmaceuticals International, plc (KNSA)
After hours:
| Previous Close | 24.49 |
| Open | 26.09 |
| Bid | 25.14 x 100 |
| Ask | 25.29 x 200 |
| Day's Range | 24.79 - 26.09 |
| 52 Week Range | 14.12 - 27.92 |
| Volume | |
| Avg. Volume | 476,251 |
| Market Cap | 1.8B |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 |
| Earnings Date | Jul 23, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.75 |
GlobeNewswireKiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 at 8:00 a.m. Eastern Time. A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximate
ZacksWall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to Trade
The consensus price target hints at a 30.1% upside potential for Kiniksa Pharmaceuticals (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ZacksZacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp
Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp have been highlighted in this Screen of The Week article.
